Binding of proinsulin and proinsulin conversion intermediates to human placental insulin-like growth factor I receptors |
| |
Authors: | P A Gruppuso B H Frank R Schwartz |
| |
Affiliation: | Division of Pediatric Metabolism, Rhode Island Hospital, Providence 02903. |
| |
Abstract: | Insulin-like growth factor I (IGF-I) and proinsulin share similarities in both primary and tertiary structure. Proinsulin, endogenously secreted or exogenously administered, would, therefore, be expected to interact with IGF-I receptors. We determined the relative activities of IGF-I, insulin, proinsulin, and the proinsulin conversion intermediates in IGF-I radioreceptor assays using term human placental membranes. Insulin was approximately 0.5% as potent as IGF-I, and proinsulin was only 2% as potent as insulin. The six major proinsulin conversion intermediates were studied; all had activities intermediate between those of insulin and proinsulin. We conclude that the binding of proinsulin and the proinsulin conversion intermediates to IGF-I receptors is not of physiological significance at the concentrations occurring endogenously or after exogenous administration of proinsulin. |
| |
Keywords: | |
|
|